Market
Understand market structure changes, launch dynamics, and access shifts that affect asset and company valuations.
4 signals
STRATEGY
Merck announced initial access plans for alimatravir, an investigational HIV PrEP, focusing on low- and middle-income countries.
STRATEGY
HPV-associated cancers in Peruvian men resulted in 5,996 outpatient consultations and 1,136 hospitalizations from 2015-2019, with a significant number of deaths attributable to HPV.
STRATEGY
The study evaluates the financial implications of introducing FF/UMEC/VI therapy for asthma in Saudi Arabia.
STRATEGY
CVS Caremark will cover Foundayo starting June 1 and Zepbound from October 1, allowing eligible patients to pay as low as $25 monthly.
Showing 1–4 of 4 records
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.